Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats
Brenda M. Gannon, Agnieszka Sulima, Kenner C. Rice, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 364, Iss. 2, pp. 359-366
Open Access | Times Cited: 24

Showing 24 citing articles:

Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67
DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants
Steven J. Simmons, Jonna M. Leyrer‐Jackson, Chicora F. Oliver, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2379-2394
Open Access | Times Cited: 49
Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
Linda D. Simmler, Matthias E. Liechti
Handbook of experimental pharmacology (2018), pp. 143-164
Open Access | Times Cited: 47
The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study
Jimmie L. Pirtle, Melissa D. Hickman, Varun C. Boinpelly, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 52-59
Open Access | Times Cited: 39
Chronic Cocaine Use and Parkinson’s Disease: An Interpretative Model
Manuel Glauco Carbone, Icro Maremmani
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 3
Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys
Stephen J. Kohut, Jack Bergman
European Journal of Pharmacology (2018) Vol. 840, pp. 28-32
Open Access | Times Cited: 31
Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.
Lisa R. Gerak, Gregory T. Collins, David R. Maguire, et al.
Experimental and Clinical Psychopharmacology (2018) Vol. 27, Iss. 1, pp. 78-86
Open Access | Times Cited: 28
Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys
Gregory T. Collins, Agnieszka Sulima, Kenner C. Rice, et al.
Psychopharmacology (2019) Vol. 236, Iss. 12, pp. 3677-3685
Open Access | Times Cited: 28
Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
Gregory T. Collins, Charles P. France
Experimental and Clinical Psychopharmacology (2018) Vol. 26, Iss. 5, pp. 488-496
Open Access | Times Cited: 24
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Converging vulnerability factors for compulsive food and drug use
Katherine M. Serafine, Laura E. O’Dell, Eric P. Zorrilla
Neuropharmacology (2021) Vol. 196, pp. 108556-108556
Open Access | Times Cited: 19
Behavioral economic analysis of the reinforcing effects of “bath salts” mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats
Brenda M. Gannon, Melson P Mesmin, Agnieszka Sulima, et al.
Psychopharmacology (2018) Vol. 236, Iss. 3, pp. 1031-1041
Open Access | Times Cited: 19
Cross-reinstatement between 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using conditioned place preference
Leticia Duart-Castells, M. Carmen Blanco-Gandía, Carmen Ferrer‐Pérez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 100, pp. 109876-109876
Closed Access | Times Cited: 12
3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 384, Iss. 3, pp. 353-362
Open Access | Times Cited: 4
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota
Mariana Angoa‐Pérez, Branislava Zagorac, Dina M. Francescutti, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
David R. Maguire
Pharmacology Biochemistry and Behavior (2023) Vol. 234, pp. 173673-173673
Open Access | Times Cited: 3
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
Ryan T. Hurt, Manpreet S. Mundi, Jon O. Ebbert
Diabetes Metabolic Syndrome and Obesity (2018) Vol. Volume 11, pp. 469-478
Open Access | Times Cited: 9
Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats
William S. Hyatt, Michael D. Berquist, Neha Milind Chitre, et al.
Behavioural Pharmacology (2019) Vol. 30, Iss. 7, pp. 555-565
Open Access | Times Cited: 7
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters
Charlotte P. Magee, Christopher L. German, Yasmeen H. Siripathane, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 374, Iss. 2, pp. 273-282
Open Access | Times Cited: 6
Lorcaserin Administration has Pro-Ejaculatory Effects in Rats via 5-HT2C Receptors Activation: A Putative Pharmacologic Strategy to Delayed Ejaculation?
Luiz Ricardo de Almeida Kiguti, Tainá Louise Pacheco, Edson Antunes, et al.
The Journal of Sexual Medicine (2020) Vol. 17, Iss. 6, pp. 1060-1071
Closed Access | Times Cited: 5
Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction
Joanna Jastrzębska, Małgorzata Frankowska, Irena Smaga, et al.
Pharmacological Reports (2022) Vol. 75, Iss. 1, pp. 99-118
Open Access | Times Cited: 3
Future Directions Incorporating Novel Medications to Reduce Repeat Overdose
Sade E. Johns, Mary Jo Bowman, F. Gerard Moeller
Current Treatment Options in Psychiatry (2018) Vol. 5, Iss. 3, pp. 313-322
Closed Access
Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of cocaine addiction and depression
Joanna Jastrzębska, Małgorzata Frankowska, Irena Smaga, et al.
Research Square (Research Square) (2022)
Open Access
Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of cocaine addiction and depression
Joanna Jastrzębska, Małgorzata Frankowska, Irena Smaga, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top